Total Payments
$20,449
2024 Payments
$1,285
Companies
56
Transactions
562
Medicare Patients
3,713
Medicare Billing
$400,866
Payment Breakdown by Category
Food & Beverage$16,129 (78.9%)
Travel$3,726 (18.2%)
Education$593.89 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,129 | 518 | 78.9% |
| Travel and Lodging | $3,726 | 7 | 18.2% |
| Education | $593.89 | 36 | 2.9% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$20,449
561 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NeoTract Inc. | $4,390 | 59 | $0 (2020) |
| Teleflex LLC | $2,587 | 31 | $0 (2024) |
| Boston Scientific Corporation | $2,407 | 31 | $0 (2024) |
| Astellas Pharma US Inc | $1,962 | 85 | $0 (2024) |
| Medtronic USA, Inc. | $1,231 | 5 | $0 (2020) |
| Intuitive Surgical, Inc. | $901.69 | 16 | $0 (2022) |
| COLOPLAST CORP | $873.51 | 61 | $0 (2024) |
| PFIZER INC. | $737.55 | 50 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $567.67 | 33 | $0 (2023) |
| Janssen Biotech, Inc. | $495.48 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,285 | 40 | Teleflex LLC ($320.91) |
| 2023 | $2,960 | 64 | Teleflex LLC ($1,157) |
| 2022 | $2,663 | 86 | Teleflex LLC ($545.82) |
| 2021 | $1,896 | 70 | Teleflex LLC ($563.16) |
| 2020 | $3,324 | 56 | Medtronic USA, Inc. ($1,123) |
| 2019 | $4,313 | 81 | NeoTract Inc. ($2,867) |
| 2018 | $2,031 | 96 | NeoTract Inc. ($443.03) |
| 2017 | $1,977 | 69 | Astellas Pharma US Inc ($396.91) |
All Payment Transactions
562 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | COLOPLAST CORP | Luja Coude (Device) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Continence Care | ||||||
| 12/03/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/21/2024 | Stryker Corporation | INFINITY (Device), AIM (ADVANCED IMAGING MODALITY), 1788 | Food and Beverage | In-kind items and services | $128.51 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 11/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: UROLOGY | ||||||
| 10/22/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $168.66 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 10/08/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: ONCOLOGY | ||||||
| 10/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: UROLOGY | ||||||
| 09/23/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $19.13 | General |
| Category: Urology | ||||||
| 09/21/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/12/2024 | BIOPROTECT MEDICAL, INC. | BIOPROTECT BALLOON IMPLANT SYSTEM (Device) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Rectal Spacers Used in Prostate Cancer Radiation Therapy | ||||||
| 09/10/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Oncology | ||||||
| 08/27/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Men's Health | ||||||
| 08/23/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: UROLOGY | ||||||
| 07/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: ONCOLOGY | ||||||
| 07/02/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Oncology | ||||||
| 06/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Oncology | ||||||
| 06/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/20/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $29.43 | General |
| Category: UROLOGY | ||||||
| 05/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Oncology | ||||||
| 05/17/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: ONCOLOGY | ||||||
| 05/16/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $150.12 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 861 | 982 | $376,985 | $73,461 |
| 2022 | 15 | 895 | 1,062 | $389,879 | $75,669 |
| 2021 | 13 | 920 | 1,129 | $369,722 | $87,199 |
| 2020 | 16 | 1,037 | 1,373 | $915,195 | $164,536 |
Total Patients
3,713
Total Services
4,546
Medicare Billing
$400,866
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 189 | 246 | $43,013 | $14,808 | 34.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 73 | 75 | $57,900 | $12,994 | 22.4% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 22 | 22 | $84,408 | $11,178 | 13.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 91 | $21,165 | $7,256 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 80 | 91 | $18,014 | $5,756 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 68 | 82 | $11,222 | $3,724 | 33.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 52 | 52 | $9,606 | $3,643 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $7,279 | $2,740 | 37.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 34 | 34 | $20,401 | $2,737 | 13.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 35 | 39 | $17,785 | $2,204 | 12.4% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 12 | 16 | $27,488 | $1,895 | 6.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $3,871 | $1,216 | 31.4% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 14 | 14 | $7,376 | $1,200 | 16.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 87 | 98 | $35,399 | $740.60 | 2.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 11 | 11 | $2,285 | $625.20 | 27.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 17 | 17 | $4,830 | $391.64 | 8.1% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 11 | 11 | $3,261 | $257.61 | 7.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 39 | 44 | $1,683 | $96.80 | 5.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 214 | 289 | $50,183 | $16,531 | 32.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 70 | 76 | $58,350 | $13,162 | 22.6% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2022 | 23 | 23 | $86,669 | $12,086 | 13.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 129 | 160 | $20,729 | $6,468 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 59 | $13,666 | $4,578 | 33.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 35 | 35 | $18,210 | $3,549 | 19.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $6,878 | $3,105 | 45.1% |
About Dr. Christopher Walsh, MD
Dr. Christopher Walsh, MD is a Urology healthcare provider based in Wauwatosa, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811966955.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Walsh, MD has received a total of $20,449 in payments from pharmaceutical and medical device companies, with $1,285 received in 2024. These payments were reported across 562 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($16,129).
As a Medicare-enrolled provider, Walsh has provided services to 3,713 Medicare beneficiaries, totaling 4,546 services with total Medicare billing of $400,866. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Wauwatosa, WI
- Active Since 03/14/2006
- Last Updated 11/14/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1811966955
Products in Payments
- UROLIFT (Device) $4,003
- UroLift (Device) $2,041
- INTERSTIM (Device) $1,306
- XTANDI (Drug) $1,116
- Da Vinci Surgical System (Device) $901.69
- UroLift System (Device) $642.18
- Xtandi (Drug) $622.37
- AMS (Device) $536.70
- XIAFLEX (Biological) $523.77
- REZUM (Device) $444.49
- ERLEADA (Drug) $388.22
- Axonics (Device) $329.32
- GREENLIGHT (Device) $319.96
- BOTOX (Biological) $302.48
- Myrbetriq (Drug) $293.51
- Urolift - UL400 (Device) $291.88
- NOCDURNA (Drug) $290.18
- XYOSTED (Drug) $286.69
- GEMTESA (Drug) $274.63
- SPEEDICATH (Device) $227.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.